In contrast, Fang et al. reported that silencing of human antigen R (HuR) ameliorated aortic valve calcification by suppressing autophagy, highlighting the potential of targeting HuR to inhibit autophagy as an innovative therapeutic strategy for CAVD [39]. This evidence concerns the gene ELAVL1 and congenital bilateral aplasia of vas deferens from CFTR mutation.